Gluconorm P15 & P30  
Worldwide
 
Overview
 

Word Search (Top 10 - by date)

Fast-replicating HIV strains drive inflammation and disease progression
International AIDS Vaccine Initiative (February 17, 2015)
AstraZeneca, MD Anderson Enter Collaboration to Help Improve Patient Outcomes in Ovarian/ Gynecologic Cancers
AstraZeneca (January 29, 2015)
Intrexon, ZIOPHARM, and MD Anderson in Exclusive CAR T Pact
Intrexon (January 13, 2015)
Amgen and MD Anderson Announce Agreement to Develop BiTE® Therapies for Myelodysplastic Syndrome
Amgen (January 12, 2015)
MD Anderson, UnitedHealthcare Launch New Cancer Care Payment Model
The University of Texas MD Anderson Cancer Center (December 15, 2014)
MD Anderson officials react to FDA Approval of Gardasil 9 for the prevention of certain cancers
The University of Texas MD Anderson Cancer Center (December 11, 2014)
Critical Outcome Technologies and Md Anderson Cancer Center to Evaluate COTI ‐ 2 in Treating Head and Neck Cancers
Critical Outcome Technologies (October 21, 2014)
Bristol-Myers Squibb and MD Anderson Cancer Center Announce Novel Research Collaboration in Immuno-Oncology Focused on Leukemia and Hematologic Malignancies
Bristol-Myers Squibb (October 06, 2014)
MedStar Georgetown to Install MEVION S250 Proton Therapy System to Treat Adult and Pediatric Cancer Patients (September 04, 2014)
Ryogen Awarded Two U.S. Patents Directed to Hepatitis C and Diabetes (August 27, 2014)

Displaying 10 out of a possible 59 unique stories.
Results Sorted By date
Display All Stories


EvaluatePharma® - the premier source for pharma and biotech analysis.

Expert integration of financial and product data across historic and forecast timeframes (1986 to 2016) delivers a vast array of analytics by product, company, therapy area, EphMRA ATC code, technology, patent status (expiry date/ number), deals (upfront/ milestones), license revenues (royalties/ co-promotion) and much more.

Product Name Information

Product: Gluconorm P15 & P30
Generic Name:   metformin hydrochloride; pioglitazone hydrochloride
Therapeutic Subcategory:     Anti-diabetics

Clinical Trial Coverage: No. of Trials involving Product

Trial Count
Gluconorm P15 & P30

Welcome

Evaluate provides market intelligence and analysis for the pharma, biotech and medtech industries.

Explore Evaluate


Partnering

EvaluatePharma® now includes Partnering Opportunities - products available for licensing.

Partnering Opportunities in EvaluatePharma® are sourced from the rights holders - all entries are verified by the team of Analysts at EvaluatePharma - and presented in their commercial context.

Register to submit your Partnering Opportunities or to see your own and other Partnering Opportunities in their commercial context with the unique industry-wide analysis in EvaluatePharma®.

Take a full subscription to see all products available for license, including updated contact details for the out-licensing entity.


Register to access more FREE content:

  • 2011 Product Sales analysis
  • Download analysis into Excel
  • Search 2 yrs of company press releases

Research Codes Synonyms

Product:1 Gluconorm P15 & P30

Register for Free Analysis

Register to access more free insights and analysis from Evaluate.

Register Now